Allarity Therapeutics News

Allarity Therapeutics | 8-K: Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances

May 15 09:20 ET

Allarity Therapeutics | 8-K: Current report

May 9 09:52 ET

Allarity Therapeutics | 8-K: Current report

May 6 09:33 ET

Allarity Therapeutics | 8-K: Current report

May 3 06:11 ET

Allarity Therapeutics | 8-K: Current report

Apr 30 08:15 ET

Allarity Therapeutics | 8-K: Current report

Apr 18 07:01 ET

Allarity Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 17 09:19 ET

ALLARITY THERAPEUTICS INC | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 8 12:38 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Apr 5 08:33 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Apr 4 17:07 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Apr 1 09:41 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 26 08:09 ET

ALLARITY THERAPEUTICS INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 25 16:35 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 20 12:37 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 15 09:15 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 8 08:40 ET

ALLARITY THERAPEUTICS INC | DEF 14A: Definitive information statements

Mar 8 06:05 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 4 16:13 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 1 09:24 ET

ALLARITY THERAPEUTICS INC | 8-K: Current report

Feb 14 09:07 ET